Photo from wikipedia
Microvascular blood flow (MBF) impairment in patients with lower extremity arterial disease (LEAD) is associated with more severe major adverse limb events (MALE). The contribution of ticagrelor on blood viscosity… Click to show full abstract
Microvascular blood flow (MBF) impairment in patients with lower extremity arterial disease (LEAD) is associated with more severe major adverse limb events (MALE). The contribution of ticagrelor on blood viscosity (BV) and BV-dependent microcirculatory blood flow (MBF) in LEAD is unknown.
Keywords:
extremity arterial;
blood;
patients lower;
arterial disease;
lower extremity;
flow
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!